Onconova Therapeutics, Inc.
-
Ticker
ONTX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Newtown, Pennsylvania
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.
Onconova Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2020 Annual Report and Form 10K
Older/Archived Annual Reports